![]() |
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
![]() |
Sponsored by: |
University of Pernambuco |
---|---|
Information provided by: | University of Pernambuco |
ClinicalTrials.gov Identifier: | NCT00844038 |
Steven-Johnson's syndrome, or great multiform erythema, appears as a systemic disturbance, with skin involvement and mucous membranes, related to several factors, such as, viral or bacterial infections and mainly the administration of medicines, in general painkillers and antibiotics. The objective of this work is report the emergence of ulcerative vesicle -bubble chronic disease in areas of lips, gum, tongue and genital mucous membrane in a 26 year-old patient, leucoderma and masculine gender, in treatment of breathing infection with sulfametoxazol-trimetropima, having been diagnosed as syndrome of Steven-Johnson.
Condition |
---|
Stevens-Johnson Syndrome |
Study Type: | Observational |
Study Design: | Case-Only, Prospective |
Official Title: | Stevens-Johnson Syndrome Associated With Antimicrobial |
Enrollment: | 1 |
Study Start Date: | August 2008 |
Study Completion Date: | December 2008 |
Primary Completion Date: | August 2008 (Final data collection date for primary outcome measure) |
Groups/Cohorts |
---|
1
Sick
|
Among the serious medicaments reactions, there are as great representative the Mucocutaneous Disorders immunological mediated. Steven-Johnson's syndrome, or great multiform erythema, appears as a systemic disturbance, with skin involvement and mucous membranes, related to several factors, such as, viral or bacterial infections and mainly the administration of medicines, in general painkillers and antibiotics. The objective of this work is report the emergence of ulcerative vesicle -bubble chronic disease in areas of lips, gum, tongue and genital mucous membrane in a 26 year-old patient, leucoderma and masculine gender, in treatment of breathing infection with sulfametoxazol-trimetropima, having been diagnosed as syndrome of Steven-Johnson.
Ages Eligible for Study: | 20 Years to 60 Years |
Genders Eligible for Study: | Male |
Accepts Healthy Volunteers: | No |
Sampling Method: | Probability Sample |
1
Inclusion Criteria:
Exclusion Criteria:
Brazil, Pernambuco | |
University of Pernambuco | |
Recife, Pernambuco, Brazil, 52021220 |
Principal Investigator: | Edwaldo Dr Dourado, Doctor | University of Pernambuco |
Responsible Party: | University of Pernambuco ( Stevens-Johnson syndrome associated with antimicrobial ) |
Study ID Numbers: | SSJ1, 558187121279 |
Study First Received: | February 12, 2009 |
Last Updated: | February 12, 2009 |
ClinicalTrials.gov Identifier: | NCT00844038 History of Changes |
Health Authority: | Brazil: Ethics Committee |
Steven-Johnson syndrome erythema multiform autoimmune disease |
Mouth Diseases Anti-Infective Agents Erythema Autoimmune Diseases Skin Diseases, Vesiculobullous |
Skin Diseases Stomatitis Stevens-Johnson Syndrome Stomatognathic Diseases |
Mouth Diseases Anti-Infective Agents Erythema Disease Stomatitis Skin Diseases Skin Diseases, Vesiculobullous |
Pharmacologic Actions Pathologic Processes Syndrome Therapeutic Uses Stevens-Johnson Syndrome Erythema Multiforme Stomatognathic Diseases |